Status:
COMPLETED
Effect of Cocoa Supplementation Peripheral and Autonomic Diabetic Neuropathy
Lead Sponsor:
Anahuac University
Conditions:
Diabetic Neuropathies
Eligibility:
All Genders
40-60 years
Phase:
NA
Brief Summary
Type 2 diabetes mellitus is a high incidence disease in Mexico and is associated with the development of chronic degenerative complications such as diabetic neuropathy. The latter manifests itself as ...
Detailed Description
Type 2 diabetes mellitus (T2DM) is a high incidence disease in Mexico and is associated with the development of chronic degenerative complications such as diabetic neuropathy. The latter manifests its...
Eligibility Criteria
Inclusion
- Adults aged 40-60 years with a diagnosis of type 2 diabetes mellitus and diabetic neuropathy
- Minimum time of diagnosis of T2DM of 5 years
- Who have a Michigan Neuropathy Screening Instrument (MNSI) score ≥2
- Male and Female
- Have them sign the informed consent letter
Exclusion
- Subjects who modify their pharmacological treatment during the study
- Subjects who do not attend one of the intermediate consultations
Key Trial Info
Start Date :
June 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 3 2024
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT05247034
Start Date
June 4 2021
End Date
September 3 2024
Last Update
May 1 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidad Anáhuac México Norte
Huixquilucan, State of Mexico, Mexico, 52786
2
Centro de Especialidades del Riñón
Naucalpan, State of Mexico, Mexico, 53100
3
Clínica de Medicina Familiar "Nueva Oxtotitlán" ISSSTE
Toluca, State of Mexico, Mexico, 50100